Laure-anne Van Bellinghen
Bonheiden, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States.
Journal: Infectious diseases and therapy
Published: December 12, 2023
Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico.
Journal: Human vaccines & immunotherapeutics
Published: June 20, 2023
Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.
Journal: Human vaccines & immunotherapeutics
Published: April 29, 2022
Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project.
Journal: Applied health economics and health policy
Published: November 23, 2019
Constrained Optimization for Pneumococcal Vaccination in Brazil.
Journal: Value in health regional issues
Published: November 20, 2019
Is adding maternal vaccination to prevent whooping cough cost-effective in Australia?
Journal: Human vaccines & immunotherapeutics
Published: May 18, 2018
Reducing Malaria Mortality at the Lowest Budget: An Optimization Tool for Selecting Malaria Preventative Interventions Applied to Ghana.
Journal: MDM policy & practice
Published: May 06, 2018
Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil - comparison of outcomes from different static model types.
Journal: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
Published: July 17, 2017
Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model.
Journal: PharmacoEconomics
Published: September 21, 2016
The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model.
Journal: PloS one
Published: September 12, 2013
Last Updated: 09/26/2026